NK-cell and B-cell deficiency with a thymic mass

New England Journal of Medicine

Volumn 364, Issue 6, 2011, Pages 586-588

  Ng, Samuel ^a   Fanta, Christopher ^a   Okam, Maureen ^a   Bhatt, Ami S ^b  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; B CELL DEFICIENCY; B LYMPHOCYTE; CASE REPORT; CLINICAL FEATURE; FEMALE; HUMAN; LETTER; LYMPHATIC SYSTEM; NATURAL KILLER CELL; NATURAL KILLER CELL DEFICIENCY; PRIORITY JOURNAL; SEVERE COMBINED IMMUNODEFICIENCY; SYMPTOM; T LYMPHOCYTE; THYMUS;

EID: 79851482553     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc1012485     Document Type: Letter

References (6)

1. Kelleher P, Misbah SA What is Good's syndrome? Immunological abnormalities in patients with thymoma. J Clin Pathol 2003;56:12-6.
2. Gascoyne DM, Long E, Veiga-Fernandes H, et al. The basic leucine zipper transcription factor E4BP4 is essential for natural killer cell development. Nat Immunol 2009;10:1118-24. [Erratum, Nat Immunol 2010;11:543.]
3. Laiosa CV, Stadfield M, Graf T. Determinants of lymphoid-myeloid lineage diversification. Annu Rev Immunol 2006;24:705-38.
4. Mullighan CG, Miller CB, Radtke I, et al. BCR-ABL1 lymphoblastic leukaemia is characterized by the deletion of Ikaros. Nature 2008;453:110-4.
5. Mullighan CG, Su X, Zhang J, et al. Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia. N Engl J Med 2009;360:470-80.
6. Wang JH, Nichogiannopoulou A, Wu L, et al. Selective defects in the development of the fetal and adult lymphoid system in mice with an Ikaros null mutation. Immunity 1996;5:537-49.